Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


03.04.2017

1 AJR Am J Roentgenol
2 Biochem Biophys Res Commun
1 Eur Radiol
1 Gastroenterology
1 Gut
2 J Gastroenterol
2 J Gastroenterol Hepatol
4 J Hepatol
2 J Pediatr Surg
1 Oncogene
2 PLoS Genet
1 PLoS One
1 Radiology
1 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. COVEY AM, Hussain SM
    Liver-Directed Therapy for Hepatocellular Carcinoma: An Overview of Techniques, Outcomes, and Posttreatment Imaging Findings.
    AJR Am J Roentgenol. 2017 Mar 28:1-10. doi: 10.2214/AJR.17.17799.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. DAININ K, Ide R, Maeda A, Suyama K, et al
    Pyridoxamine scavenges protein carbonyls and inhibits protein aggregation in oxidative stress-induced human HepG2 hepatocytes.
    Biochem Biophys Res Commun. 2017 Mar 27. pii: S0006-291X(17)30624.
    PubMed     Text format     Abstract available

  3. MAHATI S, Xiao L, Yang Y, Mao R, et al
    miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1.
    Biochem Biophys Res Commun. 2017 Mar 22. pii: S0006-291X(17)30580.
    PubMed     Text format     Abstract available


    Eur Radiol

  4. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. RICH N, Singal AG
    Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Potential New Challenge for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2016;151:1246-1248.
    PubMed     Text format    


    Gut

  6. CARLONI V, Lulli M, Madiai S, Mello T, et al
    CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression.
    Gut. 2017 Mar 30. pii: gutjnl-2016-313114. doi: 10.1136/gutjnl-2016-313114.
    PubMed     Text format     Abstract available


    J Gastroenterol

  7. KISHIDA Y, Okubo H, Ohno H, Oki K, et al
    Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model.
    J Gastroenterol. 2017 Mar 27. doi: 10.1007/s00535-017-1331.
    PubMed     Text format     Abstract available

  8. ZHANG AY, Lai CL, Huang FY, Seto WK, et al
    Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma.
    J Gastroenterol. 2017 Mar 28. doi: 10.1007/s00535-017-1334.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  9. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
    Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
    J Gastroenterol Hepatol. 2017;32:738.
    PubMed     Text format    

  10. LOURENCO LC, Horta DV, Reis J
    Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
    J Gastroenterol Hepatol. 2017;32:739.
    PubMed     Text format    


    J Hepatol

  11. BERTUCCIO P, Turati F, Carioli G, Rodriguez T, et al
    Global Trends and Predictions in Hepatocellular Carcinoma Mortality.
    J Hepatol. 2017 Mar 20. pii: S0168-8278(17)30145.
    PubMed     Text format     Abstract available

  12. PREZIOSI ME, Singh S, Valore EV, Jung CL, et al
    Mice lacking liver-specific beta-catenin develop steatohepatitis and fibrosis after iron overload.
    J Hepatol. 2017 Mar 21. pii: S0168-8278(17)30146.
    PubMed     Text format     Abstract available

  13. BHAT M, Ghali P, Bilodeau M
    Reply to: "Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?"
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30183.
    PubMed     Text format    

  14. QURINO L, Massimo R, Jan L
    Proposal of a novel MELD exception point system for hepatocellular carcinoma: Dynamics better than tumor characteristics?
    J Hepatol. 2017 Mar 24. pii: S0168-8278(17)30180.
    PubMed     Text format    


    J Pediatr Surg

  15. BARRON LK, Bao JW, Aladegbami BG, Colasanti JJ, et al
    Toll-like receptor 4 is critical for the development of resection-associated hepatic steatosis.
    J Pediatr Surg. 2017 Mar 16. pii: S0022-3468(17)30175.
    PubMed     Text format     Abstract available

  16. SHI Y, Commander SJ, Masand PM, Heczey A, et al
    Vascular invasion is a prognostic indicator in hepatoblastoma.
    J Pediatr Surg. 2017 Mar 16. pii: S0022-3468(17)30166.
    PubMed     Text format     Abstract available


    Oncogene

  17. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS Genet

  18. UNDERHILL HR, Kitzman JO, Hellwig S, Welker NC, et al
    Fragment Length of Circulating Tumor DNA.
    PLoS Genet. 2016;12:e1006162.
    PubMed     Text format     Abstract available

  19. LI Y, Tang X, He Q, Yang X, et al
    Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.
    PLoS Genet. 2016;12:e1006183.
    PubMed     Text format     Abstract available


    PLoS One

  20. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    PubMed     Text format     Abstract available


    Radiology

  21. PULLI B, Wojtkiewicz G, Iwamoto Y, Ali M, et al
    Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease.
    Radiology. 2017 Mar 30:160588. doi: 10.1148/radiol.2017160588.
    PubMed     Text format     Abstract available


    Transplant Proc

  22. OZBILGIN M, Unek T, Egeli T, Agalar C, et al
    Hepatic Artery Reconstruction With Autologous Inferior Mesenteric Artery Graft in Living Donor Liver Transplant Recipients.
    Transplant Proc. 2017;49:566-570.
    PubMed     Text format     Abstract available


    Transplantation

  23. MEHTA N, Heimbach J, Lee D, Dodge JL, et al
    Wait Time of < 6 and > 18 Months Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Proposing a Wait Time "Sweet Spot".
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001752.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: